A Pilot Study Of Using Pre- And Early (1 Week) [18f]-misonidazole Positron Emission And Computed Tomography (18F-FMISO PET/CT) Scans As An Early Treatment Response Predictor In A Series Of Head and Neck Cancer (HNC) Patients Undergoing Chemoradiation

被引：0
|
作者：
Lee, N. [1 ]
Bartlett, R. [1 ]
Lian, M. [1 ]
Fury, M. [1 ]
Sherman, E. [1 ]
Wong, R. [1 ]
Zanzonico, P. B. [1 ]
Schoeder, H. [1 ]
Humm, J. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S497 / S497
页数：1
相关论文
共 50 条
  • [21] Measurement of early treatment response in patients with recurrent or metastatic breast cancer with 18F-FLT and 18F-FDG PET/CT: a pilot study
    Su, T.
    Chan, S.
    Lui, K.
    Huang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S320 - S321
  • [22] Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
    Trinkaus, Mateya E.
    Hicks, Rodney J.
    Young, Richard J.
    Peters, Lester J.
    Solomon, Ben
    Bressel, Mathias
    Corry, June
    Fisher, Richard
    Binns, David
    McArthur, Grant A.
    Rischin, Danny
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (01) : 89 - 97
  • [23] Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F–Fluorodeoxyglucose (18F–FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study
    Christian Kelly-Morland
    Sarah Rudman
    Paul Nathan
    Susan Mallett
    Giovanni Montana
    Gary Cook
    Vicky Goh
    BMC Cancer, 17
  • [24] Early Treatment Response Monitoring Using 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography Imaging during Fractionated Radiotherapy of Head Neck Cancer Xenografts
    Huang, Jiayi
    Chunta, John L.
    Amin, Mitual
    Lee, David Y.
    Grills, Inga S.
    Wong, Ching-Yee Oliver
    Marples, Brian
    Yan, Di
    Wilson, George D.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [25] Utility of [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the initial staging and response assessment of locally advanced breast cancer patients receiving neoadjuvant chemotherapy
    Hulikal N.
    Gajjala S.R.
    Kalawat T.C.
    Kottu R.
    Yadagiri L.A.
    Indian Journal of Surgical Oncology, 2015, 6 (4) : 330 - 336
  • [26] Early Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
    Novello, Silvia
    Vavala, Tiziana
    Levra, Matteo Giaj
    Solitro, Federica
    Pelosi, Ettore
    Veltri, Andrea
    Scagliotti, Giorgio V.
    CLINICAL LUNG CANCER, 2013, 14 (03) : 230 - 237
  • [27] An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography 18F-FLT PET/CT in Prostate Adenocarcinoma
    Kairemo, Kalevi
    Ravizzini, Gregory C.
    Macapinlac, Homer A.
    Subbiah, Vivek
    DIAGNOSTICS, 2017, 7 (02)
  • [28] Early prediction of distant metastasis in patients with uterine cervical cancer treated with definitive chemoradiotherapy by deep learning using pretreatment [18F]fluorodeoxyglucose positron emission tomography/computed tomography
    Wu, Kuo-Chen
    Chen, Shang-Wen
    Hsieh, Te-Chun
    Yen, Kuo-Yang
    Chang, Chao-Jen
    Kuo, Yu-Chieh
    Chang, Ruey-Feng
    Chia-Hung, Kao
    NUCLEAR MEDICINE COMMUNICATIONS, 2024, 45 (03) : 196 - 202
  • [29] Response evaluation to primary treatment in advanced ovarian cancer patients by integrated 18F-fluorodeoxy glucose positron emission tomography/non-contrast computed tomography (18F-FDG PET/CT) in comparison with contrast enhanced CT (CECT)
    Reddy, Rama
    Patel, Chetan D.
    Kumar, Lalit
    Thulkar, Sanjay
    Malhotra, Arun
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [30] Diagnostic validity of (S)-4-(3-[18F]Fluoropropyl)-L-glutamic acid ([18F]FSPG) positron emission tomography/computed tomography (PET/CT) for the assessment of disease activity in patients with inflammatory bowel disease: a phase 2 pilot study
    Lee, D.
    Seo, M.
    Ye, B.
    Park, S.
    Chae, S.
    Hwang, S.
    Lee, S.
    Oh, S.
    Kim, J.
    Na, S.
    Koglin, N.
    Berndt, M.
    Stephens, A.
    Moon, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S299 - S300
12345